Date: 2014-07-07
Type of information: Nomination
Compound:
Company: Quantum Genomics (France)
Therapeutic area: Cardiovascular diseases
Type agreement:
Action mechanism:
Disease:
Details:
Financial terms:
Latest news: * On July 7, 2014, Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, has announced the appointment of Professor Pierre Corvol as Chairman of its Scientific Advisory Board for a period of 4 years. Pierre Corvol is a specialist of the renin-angiotensin system. He discovered the major role of this system in the regulation of arterial blood pressure.The advisory board will be composed international scientific experts in the field of cardiology. It will provide recommendations for the research and development programs of Quantum Genomics and address in particular the question of relevant biomarkers for resistant hypertension and congestive heart failure. The other members will be announced in September 2014.
